Endourologic management of malignant ureteral obstruction: Indications, results, and quality-of-life issues

Journal of Endourology

Volumn 24, Issue 1, 2010, Pages 129-142

  Sountoulides, Petros ^a   Pardalidis, Nikolaos ^a   Sofikitis, Nikolaos ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BARE METAL STENT; ENDOUROLOGY; HEMATURIA; HUMAN; MALIGNANT URETERAL OBSTRUCTION; NEPHROSTOMY; OCCLUSION; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; URETER OBSTRUCTION; URINARY DIVERSION; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; WELLBEING;

HUMANS; QUALITY OF LIFE; STENTS; URETERAL NEOPLASMS; URETERAL OBSTRUCTION; URINARY DIVERSION; UROLOGIC SURGICAL PROCEDURES;

EID: 75149133753     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0157     Document Type: Review

References (122)

1. Radecka E, Magnusson M, Magnusson A. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy. Acta Radiol 2006;47:328-331.
2. Shekarriz B, Shekarriz H, Upadhyay J, et al. Outcome of palliative urinary diversion in the treatment of advanced malignancies. Cancer 1999;85:998-1003.
3. Wong LM, Cleeve LK, Milner AD, Pitman AG. Malignant ureteral obstruction: Outcomes after intervention. Have things changed? J Urol 2007;178:178-183.
4. Gasparini M, Carroll P, Stoller M. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction. Urology 1991;38:408-412.
5. Harrington KJ, Pandha HS, Kelly SA, et al. Palliation of obstructive nephropathy due to malignancy. Br J Urol 1995; 76:101-107.
6. Russo P. Urologic emergencies in the cancer patient. Semin Oncol 2000;27:284-298.
7. Lau MW, Temperley DE, Mehta S, et al. Urinary tract obstruction and nephrostomy drainage in pelvic malignant disease. Br J Urol 1995;76:565-569.
8. Rosenberg BH, Bianco FJ Jr, Wood DP Jr, Triest JA. Stentchange therapy in advanced malignancies with ureteral obstruction. J Endourol 2005;19:63-67.
9. Emmert C, Rassler J, Kö hler U. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer. Arch Gynecol Obstet 1997;259:147-151.
10. Donat SM, Russo P. Ureteral decompression in advanced nonurologic malignancies. Ann Surg Oncol 1996;3:393-399.
11. Paul AB, Love C, Chisholm GD. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. Br J Urol 1994;74:642-645.
12. Zadra JA, Jewett MA, Keresteci AG, et al. Nonoperative urinary diversion for malignant ureteral obstruction. Cancer 1987;60:1353-1357.
13. Wilson JR, Urwin GH, Stower MJ. The role of percutaneous nephrostomy in malignant ureteric obstruction. Ann R Coll Surg Engl 2005;87:21-24.
14. Kouba E, Wallen EM, Pruthi RS. Management of ureteral obstruction due to advanced malignancy: Optimizing therapeutic and palliative outcomes. J Urol 2008;180:444-450.
15. Ishioka J, Kageyama Y, Inoue M, et al. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: Analysis of 140 cases. J Urol 2008;180: 618-621.
16. Holden S, McPhee M, Grabstald H. The rationale of urinary diversion in cancer patients. J Urol 1979;121:19-21.
17. Brin EN, Schiff M Jr, Weiss RM. Palliative urinary diversion for pelvic malignancy. J Urol 1975;113:619-622.
18. Alexander RB, Thompson N, Pockaj BA, Chang R. Dilation of lower ureteral strictures with Van Andel catheters. J Urol 1994;152:68-69.
19. Puppo P, Ricciotti G, Bozzo W, et al. Videoendoscopic retroperitoneal cutaneous ureterostomy. Techn Urol 1996;2: 10-15.
20. Lingam K, Paterson PJ, Lingam MK, et al. Subcutaneous urinary diversion: An alternative to percutaneous nephrostomy. J Urol 1994;152:70-72.
21. Shapiro MJ, Banner MP, Amendola MA, et al. Balloon catheter dilation of ureteroenteric strictures: Long-term results. Radiology 1988;168:385-387.
22. Lang EK. Transluminal dilatation of ureteropelvic junction strictures, ureteral strictures and strictures at ureteroneocystostomy sites. Radiol Clin North Am 1986;24: 601-613.
23. Richter F, Irwin RJ Jr, Watson RA, Lang EK. Endourologic management of malignant ureteral strictures. J Endourol 2000;14:583-587.
24. Meretyk KS, Albala DM, Clayman RB, et al. Endoureterotomy for treatment for ureteral strictures. J Urol 1992;147:1502-1506.
25. Cornud F, Mendelsberg M, Chretien Y, et al. Fluoroscopically guided percutaneous transrenal electroincision of ureterointestinal anastomotic strictures. J Urol 1992;147: 578-581.
26. Gibbons RP, Correa RJ Jr, Cummings KB, Mason JT. Experience with indwelling ureteral stent catheters. J Urol 1976;115:22-26.
27. Finney RP. Experience with new double J ureteral catheter stent. J Urol 1978;120:678-681.
28. Zimskind PD, Fetter TR, Willierson JL. Clinical use of longterm indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 1967;97:840-844.
29. Hyams ES, Shah O. Malignant extrinsic ureteral obstruction: A survey of urologists and medical oncologists regarding treatment patterns and p. Urology 2008; 72:51-56.
30. Feng MI, Bellman GC, Shapiro CE. Management of ureteral obstruction secondary to pelvic malignancies. J Endourol 1999;13:521-524.
31. Kanou T, Fujiyama C, Nishimura K, et al. Management of extrinsic malignant ureteral obstruction with urinary diversion. Int J Urol 2007;14:689-692.
32. Hyppolite JC, Daniels ID, Friedman EA. Obstructive uropathy in gynecologic malignancy. Detrimental effect of intraureteral stent placement and value of percutaneous nephrostomy. ASAIO J 1995;41:M318-M323.
33. Chitale SV, Scott-Barrett S, Ho ET, Burgess NA. The management of ureteric obstruction secondary to malignant pelvic disease. Clin Radiol 2002;57:1118-1121.
34. Uthappa MC, Cowan NC. Retrograde or antegrade doublepigtail stent placement for malignant ureteric obstruction? Clin Radiol 2005;60:608-612.
35. Danilovic A, Antonopoulos IM, Mesquita JL, Lucon AM. Likelihood of retrograde double-J stenting according to ureteral obstruction pathology. Int Braz J Urol 2005;31:431-436.
36. Dyer RB, Assimos DG, Regan JD. Update on interventional uroradiology. Urol Clin North Am 1997;24:623-652.
37. Zagoria RJ, Dyer RB. Do's and don't's of percutaneous nephrostomy. Acad Radiol 1999;6:370-377.
38. Ramchandani P, Cardella JF, Grassi CJ, et al; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for percutaneous nephrostomy. J Vasc Interv Radiol 2003;14:S277-S281.
39. Park DS, Park JH, Lee YT. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction. J Endourol 2002;16:153-154.
40. Docimo SG, Dewolf WC. High failure rate of indwelling ureteral stents in patients with extrinsic obstruction: Experience at 2 institutions. J Urol 1989;142:277-279.
41. Chung SY, Stein RJ, Landsittel D, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 2004;172:592-595.
42. Millward SF. Percutaneous nephrostomy: A practical approach. J Vasc Interv Radiol 2000;11:955-964.
43. Carrafiello G, Laganà D, Lumia D, et al. Direct primary or secondary percutaneous ureteral stenting: What is the most compliant option in patients with malignant ureteral obstructions? Cardiovasc Intervent Radiol 2007;30:974-980.
44. Ku JH, Lee SW, Jeon HG, et al. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: Are there differences? Urology 2004;64:895-899.
45. Patel U, Abubacker MZ. Ureteral stent placement without postprocedural nephrostomy tube: Experience in 41 patients. Radiology 2004;230:435-442.
46. Pappas P, Stravodimos KG, Mitropoulos D, et al. Role of percutaneous urinary diversion in malignant and benign obstructive uropathy. J Endourol 2000;14:401-405.
47. Huebner WA, Plas EG, Porpaczy P. Hydronephrosis in malignant tumors: Rationale and efficiency of endourological diversions. Eur J Surg Oncol 1993;19:27-32.
48. Fallon B, Onley L, Culp DA. Nephrostomy in cancer patients: To do or not to do? Br J Urol 1980;52:237-242.
49. Yossepowitch O, Lifshitz DA, Dekel Y, et al. Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol 2001;166:1746-1749.
50. Ganatra AM, Loughling KM. The management of malignant ureteral obstruction treated with ureteral stents. J Urol 2005;174:2125-2128.
51. Jeong IG, Han KS, Joung JY, et al. The outcome with ureteric stents for managing non-urological malignant ureteric obstruction. BJU Int 2007;100:1288-1291.
52. Rosevear HM, Kim SP, Wenzler DL, et al. Retrograde ureteral stents for extrinsic ureteral obstruction: Nine years' experience at University of Michigan. Urology 2007;70:846-850.
53. Kurita Y, Ihara H, Kageyama S, et al. [Percutaneous nephrostomy versus the placement of double pigtail ureteral stent for the treatment of postrenal failure secondary to malignancies.] (Jap) Nippon Jinzo Gakkai Shi 1992;34:909-912.
54. Barton DP, Morse SS, Fiorica JV, et al. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies. Obstet Gynecol 1992;80:805-811.
55. Andriole GL, Bettmann MA, Garnick MB, Richie JP. Indwelling double-J ureteral stents for temporary and permanent urinary drainage: Experience with 87 patients. J Urol 1984;131:239-241.
56. Hao P, Li W, Song C, et al. Clinical evaluation of doublepigtail stent in patients with upper urinary tract diseases: Report of 2685 cases. J Endourol 2008;22:65-70.
57. Farrell TA, Hicks ME. A review of radiologically guided percutaneous nephrostomies in 303 patients. J Vasc Interv Radiol 1997;8:769-774.
58. Lee WJ, Patel U, Patel S, Pillari GP. Emergency percutaneous nephrostomy: Results and complications. J Vasc Interv Radiol 1994;5:135-139.
59. Kaskarelis IS, Papadaki MG, Malliaraki NE, et al. Complications of percutaneous nephrostomy, percutaneous insertion of ureteral endoprosthesis, and replacement procedures. Cardiovasc Intervent Radiol 2001;24:224-228.
60. el-Faqih SR, Shamsuddin AB, Chakrabarti A, et al. Polyurethane internal ureteral stents in treatment of stone patients: Morbidity related to indwelling times. J Urol 1991; 146:1487-1491.
61. Vanderbrink BA, Rastinehad AR, Ost MC, Smith AD. Encrusted urinary stents: Evaluation and endourologic management. J Endourol 2008;22:905-912.
62. Denstedt JD, Wollin TA, Reid G. Biomaterials used in urology: Current issues of biocompatibility, infection, and encrustation. J Endourol 1998;12:493-500.
63. Beiko DT, Knudsen BE, Watterson JD, et al. Urinary tract biomaterials. J Urol 2004;171:2438-2444.
64. Riedl CR, Witkowski M, Plas E, Pflueger H. Heparin coating reduces encrustation of ureteral stents: A preliminary report. Int J Antimicrob Agents 2002;19:507-510.
65. Tenke P, Riedl CR, Jones GL, et al. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int J Antimicrob Agents 2004;23(suppl 1):S67-S74.
66. Zupkas P, Parsons CL, Percival C, Monga M. Pentosanpolysulfate coating of silicone reduces encrustation. J Endourol 2000;14:483-488.
67. Cadieux PA, Chew BH, Knudsen BE, et al. Triclosan loaded ureteral stents decrease proteus mirabilis 296 infection in a rabbit urinary tract infection model. J Urol 2006;175:2331-2335.
68. Dudley BS, Gershenson DM, Kavanagh JJ, et al. Percutaneous nephrostomy catheter use in gynecologic malignancy: M.D. Anderson Hospital experience. Gynecol Oncol 1986;24:273-278.
69. O'Toole DM, Golden AM. Evaluating cancer patients for rehabilitation potential. West J Med 1991;155:384-387.
70. Joshi HB, Okeke A, Newns N, et al. Characterization of urinary symptoms in patients with ureteral stents. Urology 2002;59:511-516.
71. Joshi HB, Adams S, Obadeyi OO, Rao PN. Nephrostomy tube or "JJ" ureteric stent in ureteric obstruction: Assessment of patient perspectives using quality-of-life survey and utility analysis. Eur Urol 2001;39:695-701.
72. Joshi HB, Stainthorpe A, Keeley FX Jr, et al. Indwelling ureteral stents: Evaluation of quality of life to aid outcome analysis. J Endourol 2001;15:151-154.
73. el-Nahas AR, El-Assmy AM, Shoma AM, et al. Self-retaining ureteral stents: Analysis of factors responsible for patients' discomfort. J Endourol 2006;20:33-37.
74. Thomas R. Indwelling ureteral stents: Impact of material and shape on patient comfort. J Endourol 1993;7:137-140.
75. Rane A, Saleemi A, Cahill D, et al. Have stent related symptoms anything to do with placement technique? J Endourol 2001;15:741-745.
76. Candela JV, Bellman GC. Ureteral stents: Impact of diameter and composition on patient symptoms. J Endourol 1997;11:45-47.
77. Hruby GW, Ames CD, Yan Y, et al. Correlation of ureteric length with anthropometric variables of surface body habitus. BJU Int 2007;99:1119-1122.
78. Jeon SS, Choi YS, Hong JH. Determination of ideal stent length for endourologic surgery. J Endourol 2007;21:906-910.
79. Joshi HB, Chitale SV, Nagarajan M, et al. A prospective randomized single-blind comparison of ureteral stents composed of firm and soft polymer. J Urol 2005;174:2303-2306.
80. Hoe JW, Tung KH, Tan EC. Re-evaluation of indications for percutaneous nephrostomy and interventional uroradiological procedures in pelvic malignancy. Br J Urol 1993;71: 469-472.
81. Grabstald H, McPhee M. Nephrostomy and the cancer patient. South Med J 1973;66:217-220.
82. Carrafiello G, Laganà D, Mangini M, et al. Complications of percutaneous nephrostomy in the treatment of malignant ureteral obstructions: Single-centre review. Radiol Med 2006;111:562-571.
83. Ekici S, Sahin A, Ozen H. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer. J Endourol 2001;15:827-829.
84. Hepperlen TW, Mardis HK, Kammandel H. The pigtail ureteral stent in the cancer patient. J Urol 1979;121:17-18.
85. Jenkins CN, Marcus AJ. The value of antegrade stenting for lower ureteric obstruction. J R Soc Med 1995;88:446-449.
86. Jones OM, John SK, Lawrance RJ, Fozard JB. Long-term survival is possible after stenting for malignant ureteric obstruction in colorectal cancer. Ann R Coll Surg Engl 2007;89:414-417.
87. Bullock KN. The biomechanical principles of upper urinary tract pressure-flow studies. Br J Urol 1983;55:136-139.
88. Coolsaet BL, Griffiths DJ, van Mastrigt R, Duyl WA. Urodynamic investigation of the wide ureter. J Urol 1980; 124:666-672.
89. Ramsay JW, Crocker RP, Ball AJ, et al. Urothelial reaction to ureteric intubation. A clinical study. Br J Urol 1987;60: 504-505.
90. Culkin DJ, Zitman R, Bundrick WS, et al. Anatomic, functional, and pathological changes from internal ureteral stent placement. Urology 1992;40:385-390.
91. Griffiths DJ, Notschaele C. The mechanisms of urine transport in the upper urinary tract: 1. The dynamics of the isolated bolus. Neurourol Urodyn 1983;2:167.
92. Mardis HK, Kroeger RM, Hepperlen TW, et al. Polyethylene double-pigtail ureteral stents. Urol Clin North Am 1982;9:95-101.
93. Brewer AV, Elbahnasy AM, Bercowsky E, et al. Mechanism of ureteral stent flow: A comparative in vivo study. J Endourol 1999;13:269-271.
94. Hafron J, Ost MC, Tan BJ, et al. Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. Urology 2006;68:911-915.
95. Ramsay JW, Payne SR, Gosling PT, et al. The effects of double J stenting on unobstructed ureters. An experimental and clinical study. Br J Urol 1985;57:630-634.
96. Hübner WA, Plas EG, Stoller ML. The double-J ureteral stent: In vivo and in vitro flow studies. J Urol 1992;148:278-280.
97. Olweny EO, Portis AJ, Afane JS, et al. Flow characteristics of 3 unique ureteral stents: investigation of a Poiseuille flow pattern. J Urol 2000;164:2099-2103.
98. Djurhuus JC, Ladefoged O, Jorgensen S. Renal pelvic function following total alloplastic replacement of ureter in pigs. Electrophysiology, renal function and morphology. Acta Chir Scand 1976;472(suppl):67-71.
99. Wenzler DL, Kim SP, Rosevear HM, et al. Success of ureteral stents for intrinsic ureteral obstruction. J Endourol 2008; 22:295-299.
100. Yachia D. Recent advances in ureteral stents. Curr Opin Urol 2008;18:241-246.
101. Liu JS, Hrebinko RL. The use of 2 ipsilateral ureteral stents for relief of ureteral obstruction from extrinsic compression. J Urol 1998;159:179-181.
102. Rotariu P, Yohannes P, Alexianu M, et al. Management of malignant extrinsic compression of the ureter by simultaneous placement of two ipsilateral ureteral stents. J Endourol 2001;15:979-983.
103. Fromer DL, Shabsigh A, Benson MC, Gupta M. Simultaneous multiple double pigtail stents for malignant ureteral obstruction. Urology 2002;59:594-596.
104. Hamm M, Rathert P. [Therapy of extrinsic ureteral obstruction by 2 parallel double-J ureteral stents.] (Ger) Urologe [A] 1999;38:150-155.
105. Okeke Z, Smith AD. Malignant ureteral obstruction: The case for plastic ureteral stents. J Endourol 2008;22:2101-2106.
106. Hannapel J, Heinrichs B, Levens W, et al. The ureteral bypass, a new method of palliative urinary diversion. Presented at the 7th European Association of Urology Congress, June 26-28, 1986, Budapest. Abstract A1522.
107. Nakada SY, Gerber AJ, Wolf JS Jr, et al. Subcutaneous urinary diversion utilizing a nephrovesical stent: A superior alternative to long-term external drainage? Urology 1995;45:538-541.
108. Desgrandchamps F, Cussenot O, Meria P, et al. Subcutaneous urinary diversions for palliative treatment of pelvic malignancies. J Urol 1995;154:367-370.
109. Jabbour ME, Desgrandchamps F, Angelescu E, et al. Percutaneous implantation of subcutaneous prosthetic ureters: Long-term outcome. J Endourol 2001;15:611-614.
110. Lloyd SN, Tirukonda P, Biyani CS, et al. The detour extraanatomic stent-a permanent solution for benign and malignant ureteric obstruction? Eur Urol 2007;52:193-198.
111. Schmidbauer J, Kratzik C, Klingler HC, et al. Nephrovesical subcutaneous ureteric bypass: Long-term results in patients with advanced metastatic disease-improvement of renal function and quality of life. Eur Urol 2006;50:1073-1078.
112. Desgrandchamps F, Leroux S, Ravery V, et al. Subcutaneous pyelovesical bypass as replacement for standard percutaneous nephrostomy for palliative urinary diversion: Prospective evaluation of patient's quality of life. J Endourol 2007;21:173-176.
113. Nissenkorn I, Gdor Y. Nephrovesical subcutaneous stent: An alternative to permanent nephrostomy. J Urol 2000; 163:528-530.
114. Schlick R, Seidel EM, Kalem T, et al. New endoureteral double-J stent resists extrinsic ureteral compression. J Endourol 1998;12:37-40.
115. Tligui M, Nouri M, You R, et al. [Value of cloverleaf double J ureteral stents in the treatment of extrinsic ureteral compression.] (Fre) Prog Urol 2000;10:92-94.
116. Borin JF, McDougall EM. Ureteral stents for ureteral stricture. In: Baba S, Ono Y, eds. Interventional Management of Urological Diseases. New York: Springer, 2006, pp 81.
117. Blaschko SD, Deane LE, Krebs A, et al. In-vivo evaluation of flow characteristics of novel metal ureteral stent. J Endourol 2007;21:780-783.
118. Borin JF, Tyson D, Sala LG, et al. Encrustation of biomaterials in an in-vivo rabbit model. J Endourol 2005;19:A284.
119. Pedro RN, Hendlin K, Kriedberg C, Monga M. Wire-based ureteral stents: Impact on tensile strength and compression. Urology 2007;70:1057-1059.
120. Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol 2006;20:300-304.
121. Wah TM, Irving HC, Cartledge J. Initial experience with the resonance metallic stent for antegrade ureteric stenting. Cardiovasc Intervent Radiol 2007;30:705-710.
122. Rashid T, Foley CL, Briggs TP. Re: Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol 2007; 21:795.